Back to 
Cullen/Frost Bankers, Inc.
Cullen/Frost Bankers, Inc.
MRNA
Showing 5 of 17 quarters
Position history for Cullen/Frost Bankers, Inc.'s holdings in Moderna, Inc.
No. Cullen/Frost Bankers exited its MRNA (Moderna) position in Q1 2026. Its Q4 2025 13F listed 14 shares worth $413. Cullen/Frost Bankers first reported MRNA in Q3 2021 and held it in 14 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$1,537
Total Shares Change
-23
Quarter-by-Quarter History
Other major holders of MRNA: Baillie Gifford & Co.